What’s the difference between Wegovy and Ozempic, and how are they prescribed in Europe?

Wegovy vs Ozempic explained: semaglutide dosing, approved indications, weight loss vs type 2 diabetes, side effects, and eligibility criteria.

In this episode, we compare Wegovy and Ozempic — both containing semaglutide — and clarify how they differ in licensing, dosing, and clinical use under EU medical guidance.

You’ll learn:

• The active ingredient (semaglutide) and how GLP-1 receptor agonists work

• Why Wegovy is approved for weight management and Ozempic for type 2 diabetes

• Differences in maximum dosing and titration schedules

• Typical side effects such as nausea, vomiting, and gastrointestinal discomfort

• BMI thresholds and metabolic criteria used in eligibility assessment